NCT02103569 Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325 Status COMPLETED Phase PHASE1
NCT02100228 Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) Status COMPLETED Phase PHASE4
NCT02098616 Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus Status COMPLETED Phase NA
NCT02097966 EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C Status NO_LONGER_AVAILABLE Phase N/A
NCT02097277 A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes Status COMPLETED Phase PHASE2
NCT02095860 Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 Status COMPLETED Phase PHASE1
NCT02090556 Long-term Experience With Abatacept SC in Routine Clinical Practice Status COMPLETED Phase N/A
NCT02084953 Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02082548 Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT02079480 Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects Status TERMINATED Phase PHASE1
NCT02078882 Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis Status COMPLETED Phase PHASE4
NCT02074358 A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02068053 Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020 Status COMPLETED Phase PHASE1
NCT02067910 Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome Status COMPLETED Phase PHASE3
NCT02066636 A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Status COMPLETED Phase PHASE3